Status:
COMPLETED
Model Study on Cervical Cancer Screening Strategies and Risk Prediction
Lead Sponsor:
Fujian Maternity and Child Health Hospital
Conditions:
Cervical Cancer Screening
Risk Assessment
Eligibility:
FEMALE
25-64 years
Brief Summary
By collecting non-image medical data of women undergoing cervical screening in multiple centers in China, including age, HPV infection status, HPV infection type, TCT results, and colposcopy biopsy pa...
Detailed Description
By collecting non-image medical data of women undergoing cervical screening in multiple centers in China, including age, HPV infection status, HPV infection type, TCT results, and colposcopy biopsy pa...
Eligibility Criteria
Inclusion
- Age 25-64 years old;
- There was no history of precancerous lesions or cervical cancer;
- No previous cervical surgery or cervical removal;
Exclusion
- HPV test results are not available;
- Pregnant or lactating women;
- There is a serious immune system disease, and the disease is active;
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
1112846 Patients enrolled
Trial Details
Trial ID
NCT06204133
Start Date
November 1 2023
End Date
June 30 2024
Last Update
July 22 2024
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Fujian Maternity and Child Health Hospital
Fuzhou, Fujian, China, 350001
2
Ningde maternal and child health hospital
Ningde, Fujian, China
3
Gansu Provincial Maternity and Child-care Hospital
Lanzhou, Ganshu, China
4
Shunde Women's and Children's Hospital of Guangdong Medical University
Foshan, Guangdong, China